Table 1.
APAC procedures and corresponding amounts changed by Ordinance No. 90 of March 15th, 2011 and by Ordinance No. 103 of January 30th, 2015.
| Code | Procedure | Value | Type of funding |
|---|---|---|---|
| 03.04.03.009-0 | Chemotherapy for chronic myeloid leukemia in blast phase – positive marker – without chronic phase or previous transformation – 1st line | USD4.19 | Average and high complexity (MAC) |
| 03.04.03.011-2 | Chemotherapy for chronic myeloid leukemia in chronic phase – positive marker – 1st line | USD4.19 | Average and high complexity (MAC) |
| 03.04.03.015-5 | Chemotherapy for chronic myeloid leukemia in transformation phase – positive marker – no previous chronic phase – 1st line |
USD4.19 | Average and high complexity (MAC) |
| 03.04.03.008-2 | Chemotherapy for Chronic Myeloid Leukemia in Blast Phase – 2nd line | USD20.94 | Average and High Complexity (MAC) |
| 03.04.03.014-7 | Chemotherapy for chronic myeloid leukemia in transformation phase – 2nd line | USD4.19 | Average and high complexity (MAC) |
| 03.04.03.022-8 | Chemotherapy for chronic myeloid leukemia in chronic phase – 2nd line | USD4.19 | Average and high complexity (MAC) |
1USD = 4.06BRL (17.12.2019).